Arbutus Biopharma (ABUS) Interest & Investment Income (2013 - 2026)
Arbutus Biopharma (ABUS) reported Interest & Investment Income of $842,000 for Q2 2026, down 19.2% from $1.04 million a year earlier but up 3.3% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Interest & Investment Income (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Arbutus Biopharma's Interest & Investment Income came in at $3.49 million, down 36.0% year-over-year; for FY2025, it came in at $4.07 million, down 38.2% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of 40.6% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $6.59 million in FY2024 (+15.8%), $5.69 million in FY2023 (+159.5%), $2.19 million in FY2022 and $127,000 in FY2021 (-82.9%).
- Five-year quarterly Interest & Investment Income spans a low of $27,000 in Q3 2021 and a high of $1.83 million in Q2 2024.
- Year over year, Interest & Investment Income has now declined in each of the last seven quarters, with an average decline of 23.2% over the last eight quarters.
- The high point for year-over-year Interest & Investment Income in five years was Q1 2023 (growth of 697.5%); the low point was Q3 2021 (a decline of 73.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $815,000 (Q1 2026), $877,000 (Q4 2025) and $952,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Arbutus Biopharma | 879.47 Mn | 506.45 Mn | - | 842,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 842,000.00 |
| Mar 31, 2026 | 815,000.00 |
| Dec 31, 2025 | 877,000.00 |
| Sep 30, 2025 | 952,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.83 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 943,000.00 |
| Sep 30, 2022 | 694,000.00 |
| Jun 30, 2022 | 396,000.00 |
| Mar 31, 2022 | 159,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 27,000.00 |
API Access
Arbutus Biopharma Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();